Nipro Corporation (Nipro) carries out the manufacturing, development and sale of renal and medical surgical products. The company’s products find application in fields such as cardiology, urology and nephrology, interventional radiology and anesthesiology. Its product portfolio includes renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, diabetic products and ENZYMES products among others. Nipro offers contract manufacturing services in various fields such as oral dosage forms and injection drugs, active pharmaceutical ingredients (APIs) and components. Nipro distributes its products through direct sales forces, sales companies in Germany, Turkey, Switzerland, England, Serbia, and South Africa and through distribution agent in South Korea. It has manufacturing facilities located in Japan, Brazil, Spain and the US. Nipro is headquartered in Osaka, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Nipro Corporation - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Our reports have been used by over 10K customers, including:
The South and Central America medical writing market is expected to reach US$ 362.35 million by 2027 from US$ 217.01 million in 2019; it is anticipated to grow at a CAGR of 6.6% from 2020-2027. The growth of South and Central America medical writing market is driven by the rising government support to the healthcare sector and increasing...
Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions.It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage.Its major products include cochlear implant...
Summary Compumedics Ltd (Compumedics) is a medical device company.It develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems.It provides product categories such as sleep diagnostics, neurology diagnostics, brain research...
The global live cell imaging market size is projected to reach USD 2.8 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 8.8% during the forecast period. The market for live cell imaging is driven primarily by the factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer,...
The research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research...
Increasing R&D spending and initiatives for rare disease and orphan drugs research are set to drive the drug discovery services market.’’
The drug discovery services market is projected to reach USD 21.4 billion by 2025 from USD 11.1 billion in 2020, at a CAGR of 14.0% during the forecast period. The major factors driving the growth of...
2020 Diarrhea PIPELINE HIGHLIGHTS
Diarrhea is one of the widely researched conditions during 2020 with 29 companies actively focusing on realizing pipeline’s potential. Development of Diarrhea medicines is identified as integral to the strategy of the majority of companies operating in the industry.
Rising focus on the analytical testing of biologics and biosimilars to drive market growth The global bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth in this market is attributed to the rising focus...
This IDC Perspective analyzes the role of ICT in supporting life sciences companies in the fight against COVID-19, highlighting early experiences from companies operating in Europe and worldwide. The study discusses how digital technologies can help accelerate life sciences efforts during the crisis at all levels, from R&D to supply chain...
Opioid Use Disorder: Opportunity Analysis and Forecasts to 2028
Opioids are synthetic or natural agents that stimulate opioid receptors in the brain and nervous system.Opioids are often used to treat patients suffering from pain.
When taken in the prescribed quantities, opioids...
Use Of Prescription Drugs
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.